Applying Synthetic Lethality for the Selective Targeting of Cancer von McLornan, Donal P, List, Alan, Mufti, Ghulam J

Volltext

Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress? von Mahdi, Dina, Spiers, Jessica, Rampotas, Alexandros, Polverelli, Nicola, McLornan, Donal P

Volltext

State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019 von McLornan, Donal P, Yakoub-Agha, Ibrahim, Robin, Marie, Chalandon, Yves, Harrison, Claire N, Kroger, Nicolaus

Volltext

Bone marrow niche dysregulation in myeloproliferative neoplasms von Curto-Garcia, Natalia, Harrison, Claire, McLornan, Donal P

Volltext

Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey von Passweg, Jakob R., Baldomero, Helen, Ciceri, Fabio, Corbacioglu, Selim, de la Cámara, Rafael, Dolstra, Harry, Glass, Bertram, Greco, Raffaella, McLornan, Donal P., Neven, Bénédicte, de Latour, Régis Peffault, Perić, Zinaida, Ruggeri, Annalisa, Snowden, John A., Sureda, Anna

Volltext

Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation von Hamerschlak, Nelson, Gómez-Almaguer, David, McLornan, Donal P

Volltext

‘Fine tuning’ Conditioning Protocols for Myelofibrosis to Reduce Graft Failure: are we making progress? von McLornan, Dr. Donal P.

Volltext

Differential inhibition of T-cell receptor and STAT5 signaling pathways determines the immunomodulatory effects of dasatinib in chronic phase chronic myeloid leukemia von Harrington, Patrick, Dillon, Richard, Radia, Deepti, Rousselot, Philippe, McLornan, Donal P, Ong, Mark, Green, Anna, Verde, Alessandro, Hussain, Farzana, Raj, Kavita, Kordasti, Shahram, Harrison, Claire, De Lavallade, Hugues

Volltext

Current and future status of JAK inhibitors von McLornan, Donal P, Pope, Janet E, Gotlib, Jason, Harrison, Claire N

Volltext

Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia von Gunawan, Arief S, McLornan, Donal P, Wilkins, Bridget, Waghorn, Katherine, Hoade, Yvette, Cross, Nicholas C P, Harrison, Claire N

Volltext

Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms von Herlihy, Naoimh, Harrison, Claire N, McLornan, Donal P

Volltext

Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT von Gurnari, Carmelo, McLornan, Donal P.

Volltext

Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry von Hernández‐Boluda, Juan‐Carlos, Pereira, Arturo, Kröger, Nicolaus, Cornelissen, Jan J., Finke, Jürgen, Beelen, Dietrich, Witte, Moniek, Wilson, Keith, Platzbecker, Uwe, Sengeloev, Henrik, Blaise, Didier, Einsele, Hermann, Sockel, Katja, Krüger, William, Lenhoff, Stig, Salaroli, Adriano, Martin, Hans, García‐Gutiérrez, Valentín, Pavone, Vicenzo, Alvarez‐Larrán, Alberto, Raya, José‐María, Zinger, Nienke, Gras, Luuk, Hayden, Patrick, Czerw, Tomasz, P. McLornan, Donal, Yakoub‐Agha, Ibrahim

Volltext

Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT von Drozd-Sokolowska, Joanna, Gras, Luuk, Koster, Linda, Martino, Rodrigo, Salas, María Queralt, Salmenniemi, Urpu, Zudaire, Teresa, Yañez, Lucrecia, Bellido, Mar, Collin, Matthew, Kaufmann, Martin, Kozlowski, Piotr, Poiré, Xavier, Ferra, Christelle, Sampol, Antònia, Wilson, Keith M O, Cairoli, Anne, Gedde-Dahl, Tobias, Deconinck, Eric, Mirabile, Milena, Suarez, Felipe, Raj, Kavita, Van Gelder, Michel, Yakoub-Agha, Ibrahim, Tournilhac, Olivier, McLornan, Donal P

Volltext

Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012 von McLornan, Donal P., Mead, Adam J., Jackson, Graham, Harrison, Claire N.

Volltext

Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations von Alimam, Samah, McLornan, Donal P, Jiang, Jie, Radia, Deepti, Mufti, Ghulam J, Harrison, Claire N

Volltext

Beneficial effects of JAK inhibitor therapy in Systemic Mastocytosis von Dowse, Robin, Ibrahim, Maria, McLornan, Donal P., Moonim, Mufaddal T., Harrison, Claire N., Radia, Deepti H.

Volltext

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys) von Okikiolu, Jumoke, Woodley, Claire, Cadman-Davies, Llywelyn, O'Sullivan, Jennifer, Radia, Deepti, Garcia, Natalia Curto, Harrington, Patrick, Kordasti, Shahram, Asirvatham, Susan, Sriskandarajah, Priya, Saunders, Jamie, Saha, Chandan, Sanchez, Irene, deLavallade, Hugues, McLornan, Donal P, Harrison, Claire N

Volltext

Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis von Oh, Stephen T., Verstovsek, Srdan, Gupta, Vikas, Platzbecker, Uwe, Devos, Timothy, Kiladjian, Jean‐Jacques, McLornan, Donal P., Perkins, Andrew, Fox, Maria Laura, McMullin, Mary Frances, Mead, Adam J., Egyed, Miklos, Mayer, Jiri, Sacha, Tomasz, Kawashima, Jun, Huang, Mei, Strouse, Bryan, Mesa, Ruben

Volltext

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis von McMullin, Mary F. F., Mead, Adam J., Ali, Sahra, Cargo, Catherine, Chen, Frederick, Ewing, Joanne, Garg, Mamta, Godfrey, Anna, Knapper, Steven, McLornan, Donal P., Nangalia, Jyoti, Sekhar, Mallika, Wadelin, Frances, Harrison, Claire N.

Volltext